- Report
- October 2023
- 181 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- December 2022
- 113 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2023
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2021
- 527 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Book
- March 2022
- 896 Pages
- Book
- November 2011
- 496 Pages
Global
- Book
- October 2018
- 714 Pages
Within the field of genomics, the transgenic animal market refers to the sector that develops and supplies animals that have been genetically engineered to possess and express an exogenous gene. These animals are produced for various purposes, including research, pharmaceutical development, agriculture, and industrial applications. The incorporation of genomics in creating transgenic animals allows for the precise manipulation of DNA to introduce traits that can result in disease models for medical research, enhanced production traits in livestock, or the production of therapeutic proteins. The use of CRISPR/Cas9 technology, along with other gene-editing tools, has expanded the possibilities within this market.
Transgenic animals are also valuable in the study of gene function and regulation, as they help to provide insights into genetic diseases, developmental biology, and gene interactions within an intact organism. The area has grown to encompass the development of not only transgenic mice and rats, which are staples in laboratory research, but also larger animals such as pigs, cows, and goats that can serve as bioreactors for producing pharmaceuticals within their milk or blood.
Some notable companies in the transgenic animal market include GenOway, Horizon Discovery Group plc, TransGenic Inc., and Cyagen Biosciences Inc. These companies offer a range of services, including the custom creation of transgenic animal models, technologies for genetic modification, and support for academic and industrial research. Show Less Read more